Roger Adsett - 01 Apr 2026 Form 4 Insider Report for INSMED Inc (INSM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Apr 2026, 16:07:37 UTC
Prior SEC filing
04 Feb 2026
Next SEC filing
15 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Roger Adsett, by Michael A. Smith as Attorney-in-fact

Key filing fact

Roger Adsett filed Form 4 for INSMED Inc (INSM) on 03 Apr 2026.

Key facts

  • This page summarizes Roger Adsett's Form 4 filing for INSMED Inc (INSM).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Apr 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 04 Feb 2026.
  • Current net transaction value: -$14,497,651.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001685904 Primary reporting owner

Adsett Roger

Relationship
Chief Operating Officer
Address
700 US HIGHWAY 202/206, BRIDGEWATER
Signature
/s/ Roger Adsett, by Michael A. Smith as Attorney-in-fact
Signature date
03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Options Exercise

Transaction value
Shares
+88,060
Change %
+82%
Price
$14.56*
Shares after
194,870
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1
INSM transaction

Common Stock

Sale

Transaction value
$1,095,754
Shares
-6,715
Change %
-3.4%
Price
$163.18
Shares after
188,155
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1, F2
INSM transaction

Common Stock

Sale

Transaction value
$3,118,254
Shares
-19,001
Change %
-10%
Price
$164.11
Shares after
169,154
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1, F3
INSM transaction

Common Stock

Sale

Transaction value
$10,283,643
Shares
-62,344
Change %
-37%
Price
$164.95
Shares after
106,810
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INSM transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-88,060
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
88,060
Exercise price
$14.56
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Footnote F2

This is the weighted average sales price representing 6,715 shares sold at prices ranging from $162.52 to $163.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Footnote F3

This is the weighted average sales price representing 19,001 shares sold at prices ranging from $163.52 to $164.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Footnote F4

This is the weighted average sales price representing 62,344 shares sold at prices ranging from $164.52 to $165.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Footnote F5

The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .